Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

NCRI 2010 /
Advances in the treatment of renal cancer

7th - 10th Nov 2010

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 11.01.11
Views: 4624
Rating:

Prof Tim Eisen - University of Cambridge, UK

Prof Tim Eisen speaks about a session at NCRI 2010 which looks at the advances we have made in our understanding of renal cancer over the last ten to fifteen years. The guest speakers at this talk will be Eamonn Maher (University of Birmingham), Inderbir Gill (University of Southern California) and Cora Sternberg (San Camillo Forlanini Hospital in Rome). Prof Eisen talks about the advances that have been made treating this cancer with anti-angiogenic drugs, gives example of the most effective treatments, but also notes that a small proportion of patients are better off treated with immunotherapy and explains how much more work needs to be done before a cure for renal cancer is found.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation